510(k) Report

510(k) · Cleared

Cleared

Perfect-O Ostial Positioning Catheter

K260289510(k) TraditionalCleared Jun 5, 2026127-day reviewClass II21 CFR 870.1250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Balosmark, Inc. · DQY Catheter, Percutaneous

Cleared on Jun 5, 2026 as substantially equivalent to K122089 (Merit Medical Systems, Inc., 2012) after a 127-day review. Its family tree reaches back 6 generations to 1997.

Decided
Jun 5, 2026
Review
127 days
Class
Class II
Product code
DQY
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K970376 (1997). 18 ancestors in all, the oldest K893626 (1989). No later device cites it as a predicate yet.

  1. Root · 6 generations backK970376 Ptca GuidewireLake Region Mfg., Inc. · 1997
  2. 5 generations backK011968 Streerable Ptca GuidewireLake Region Mfg., Inc. · 2001 · Recalled
  3. 4 generations backK022813 Steerable GuidewireLake Region Mfg., Inc. · 2003
  4. 3 generations backK042338 Coronary Peripheral and Renal Steerable GuidewireLake Region Mfg., Inc. · 2004
  5. 2 generations backK062192 Ostial Pro Stent Positioning SystemOstial Solutions, LLC · 2007
  6. 1 generation backK122089 Ostial Pro Stent Positioning SystemMerit Medical Systems, Inc. · 2012
  7. This deviceK260289 Perfect-O Ostial Positioning CatheterBalosmark, Inc. · 2026
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K970376Ptca GuidewireLake Region Mfg., Inc.1997—
−5K011968Streerable Ptca GuidewireLake Region Mfg., Inc.20012
−4K022813Steerable GuidewireLake Region Mfg., Inc.2003—
−3K042338Coronary Peripheral and Renal Steerable GuidewireLake Region Mfg., Inc.2004—
−2K062192Ostial Pro Stent Positioning SystemOstial Solutions, LLC2007—
−1K122089Ostial Pro Stent Positioning SystemMerit Medical Systems, Inc.2012—
0 (this device)K260289Perfect-O Ostial Positioning CatheterBalosmark, Inc.2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198910
199110
199530
200010
200110
200210
200330
200610
FIG. 1 — Lineage of K260289, 1997–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DQY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DQY device

  1. #1 K234115 APRO 55 Catheterscore 17.5 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K122089Ostial Pro Stent Positioning System
Summary page 5
…O Ostial Positioning Catheter Common / Usual Name Percutaneous Catheter Classification Name 21 CFR 870.1250, DQY, Class II Predicate Device K122089, Ostial Pro Stent Positioning System (Merit Medical Systems, Inc) Device Description The Perfect-O is a medical-grade, disposa…
Merit Medical Systems, Inc.2012—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 29 years and passes through 4 companies; a new generation was cleared every 4.1 years on median.
  • 1 of the 18 ancestors has a recall of any class.

How does its category compare?

All DQY devices

DQY Catheter, Percutaneous: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · DQY

21in 2025

2007: 162008: 312009: 372010: 222011: 362012: 302013: 322014: 192015: 272016: 222017: 262018: 252019: 302020: 202021: 182022: 182023: 182024: 162025: 212026 (partial year): 11
2007high 37 (2009) · low 16 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DQY

115in 2025

2007: 85 days median2008: 66 days median2009: 73 days median2010: 74 days median2011: 71 days median2012: 87 days median2013: 92 days median2014: 127 days median2015: 118 days median2016: 117 days median2017: 113 days median2018: 106 days median2019: 111 days median2020: 120 days median2021: 81 days median2022: 74 days median2023: 114 days median2024: 87 days median2025: 115 days median2026 (partial year): 30 days median
2007high 127 (2014) · low 66 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DQY

1in 2025

2007: 62008: 122009: 172010: 322011: 62012: 22013: 36, 1 Class I2014: 32015: 32016: 22, 7 Class I2017: 82018: 22019: 12020: 22021: 22023: 172024: 12025: 1, 1 Class I2026 (partial year): 2, 1 Class I
2007high 36 (2013) · low 0 (2022)2026

Class I (10 since 2007) Class II/III not classified

Adverse event reports per year · DQY

3,056in 2025

2007: 3132008: 4962009: 8192010: 1,2932011: 1,2112012: 1,1912013: 1,3522014: 1,4972015: 2,3372016: 2,2522017: 2,4892018: 2,8552019: 2,9022020: 2,8892021: 3,0062022: 2,6432023: 3,0492024: 3,1902025: 3,056
2007high 3,190 (2024) · low 313 (2007)2025

MAUDE reports naming product code DQY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200716856313
2008316612496
2009377317819
20102274321,293
2011367161,211
2012308721,191
2013329236 (1)1,352
20141912731,497
20152711832,337
20162211722 (7)2,252
20172611382,489
20182510622,855
20193011112,902
20202012022,889
2021188123,006
2022187402,643
202318114173,049
2024168713,190
2025211151 (1)3,056
202611302 (1)—

What is it indicated for?

The Perfect-O Ostial Positioning Catheter is intended for use in aorto-ostial procedures to introduce and position stents and other interventional devices within the coronary and peripheral vasculature. In addition, the Perfect-O Ostial Positioning Catheter is intended to facilitate the alignment of interventional devices and function as an alignment tool. The Perfect-O Ostial Positioning Catheter is not intended for use and has not been evaluated for use in the neurovasculature.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K260289: Perfect-O Ostial Positioning Catheter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K260289

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded Oct 30, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026